Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates

George Ricaurte, Annis O. Mechan, Jie Yuan, George Hatzidimitriou, Tao Xie, Andrew H. Mayne, Una D McCann

Research output: Contribution to journalArticle

Abstract

Pharmacotherapy with amphetamine is effective in the management of attention-deficit/hyperactivity disorder (ADHD), now recognized in adults as well as in children and adolescents. Here we demonstrate that amphetamine treatment, similar to that used clinically for adult ADHD, damages dopaminergic nerve endings in the striatum of adult nonhuman primates. Furthermore, plasma concentrations of amphetamine associated with dopaminergic neurotoxicity in nonhuman primates are on the order of those reported in young patients receiving amphetamine for the management of ADHD. These findings may have implications for the pathophysiology and treatment of ADHD. Further preclinical and clinical studies are needed to evaluate the dopaminergic neurotoxic potential of therapeutic doses of amphetamine in children as well as adults.

Original languageEnglish (US)
Pages (from-to)91-98
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume315
Issue number1
DOIs
StatePublished - Oct 2005

Fingerprint

Nerve Endings
Amphetamine
Attention Deficit Disorder with Hyperactivity
Primates
Therapeutics
Drug Therapy

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{92f1eb5ff3534146909df9f12fefead6,
title = "Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates",
abstract = "Pharmacotherapy with amphetamine is effective in the management of attention-deficit/hyperactivity disorder (ADHD), now recognized in adults as well as in children and adolescents. Here we demonstrate that amphetamine treatment, similar to that used clinically for adult ADHD, damages dopaminergic nerve endings in the striatum of adult nonhuman primates. Furthermore, plasma concentrations of amphetamine associated with dopaminergic neurotoxicity in nonhuman primates are on the order of those reported in young patients receiving amphetamine for the management of ADHD. These findings may have implications for the pathophysiology and treatment of ADHD. Further preclinical and clinical studies are needed to evaluate the dopaminergic neurotoxic potential of therapeutic doses of amphetamine in children as well as adults.",
author = "George Ricaurte and Mechan, {Annis O.} and Jie Yuan and George Hatzidimitriou and Tao Xie and Mayne, {Andrew H.} and McCann, {Una D}",
year = "2005",
month = "10",
doi = "10.1124/jpet.105.087916",
language = "English (US)",
volume = "315",
pages = "91--98",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates

AU - Ricaurte, George

AU - Mechan, Annis O.

AU - Yuan, Jie

AU - Hatzidimitriou, George

AU - Xie, Tao

AU - Mayne, Andrew H.

AU - McCann, Una D

PY - 2005/10

Y1 - 2005/10

N2 - Pharmacotherapy with amphetamine is effective in the management of attention-deficit/hyperactivity disorder (ADHD), now recognized in adults as well as in children and adolescents. Here we demonstrate that amphetamine treatment, similar to that used clinically for adult ADHD, damages dopaminergic nerve endings in the striatum of adult nonhuman primates. Furthermore, plasma concentrations of amphetamine associated with dopaminergic neurotoxicity in nonhuman primates are on the order of those reported in young patients receiving amphetamine for the management of ADHD. These findings may have implications for the pathophysiology and treatment of ADHD. Further preclinical and clinical studies are needed to evaluate the dopaminergic neurotoxic potential of therapeutic doses of amphetamine in children as well as adults.

AB - Pharmacotherapy with amphetamine is effective in the management of attention-deficit/hyperactivity disorder (ADHD), now recognized in adults as well as in children and adolescents. Here we demonstrate that amphetamine treatment, similar to that used clinically for adult ADHD, damages dopaminergic nerve endings in the striatum of adult nonhuman primates. Furthermore, plasma concentrations of amphetamine associated with dopaminergic neurotoxicity in nonhuman primates are on the order of those reported in young patients receiving amphetamine for the management of ADHD. These findings may have implications for the pathophysiology and treatment of ADHD. Further preclinical and clinical studies are needed to evaluate the dopaminergic neurotoxic potential of therapeutic doses of amphetamine in children as well as adults.

UR - http://www.scopus.com/inward/record.url?scp=25644446107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25644446107&partnerID=8YFLogxK

U2 - 10.1124/jpet.105.087916

DO - 10.1124/jpet.105.087916

M3 - Article

C2 - 16014752

AN - SCOPUS:25644446107

VL - 315

SP - 91

EP - 98

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -